Shockwave Medical, Inc.
NasdaqGS:SWAV
$ 330.00
$0.00 (0.00%)
$ 330.00
$0.00 (0.00%)
End-of-day quote: 04/27/2024

Shockwave Medical financials at a glance

The revenue of Shockwave Medical is reported as 0.72678 billion Dollars in the fiscal year 2023. The earnings were 3.55 Dollars per share in 2023, which was 37.72 lower than 2022. And about 0 billion Dollars are reported as free cash flow in the financials of Shockwave Medical 2023. No dividends were paid to the shareholders of the Shockwave Medical stock NasdaqGS:SWAV in the financial year 2023.

$726.78M
Revenue
$3.55
Earnings Per Share
86.94%
Gross Margin %
$280.20M
Free Cash Flow
Revenue
726.78
Earnings Per Share
3.55
Gross Margin %
86.94
Free Cash Flow
280.20

Financials

Year Year TTM 2023 2022 2021 2020 2019 2018
Rev. Revenue N/A $726.78M $489.73M $237.15M $67.79M $42.93M $12.26M
GM % Gross Margin % 86.95% 86.94% 86.73% 82.53% 69.03% 60.03% 40.88%
OM Operating Margin 24.41% 21.79% 25.35% -0.37% -96.86% -,120.76% 0.00%
EPS Earnings Per Share $6.39 $3.55 $5.70 $-0.26 $-1.99 $-2.14 $-1.91
Div. Dividends N/A $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
PR % Payout Ratio % 0 0.00% 0.00% 0 -0.00% -0.00% -0.00%
Sha. Shares N/AM 0M 36.5M 35.65M 34.84M 31.77M 1.82M
OCF Operating Cash Flow N/A $0.00M $0.00M $0.00M $0.00M $0.00M $0.00M
FCF Free Cash Flow N/A $280.20M $0.00M $2.60M $0.00M $0.00M $0.00M
FCFS Free Cash Flow Per Share $3.92 $0.00 $2.58 $0.07 $-2.50 $-2.17 $-24.73